Glenmark receives ‘India Pharma Innovation of the Year’ Award from the Govt. of India
- The prestigious award was conferred by the Department of Pharmaceuticals (DoP), Ministry of
Chemicals & Fertilizers.
- This is the fourth time Glenmark has won an award from the Govt. of India
- The Award recognizes Glenmark’s multiple patents and commercialized innovations over the last
Mumbai, India; February 2021: Glenmark Pharmaceuticals, a research-led, global integrated pharmaceutical
company, today received the “India Pharma Innovation of the Year” Award, as part of the India Pharma & India
Medical Device Awards 2021. The 6th edition of the annual awards is jointly organized by the Department of
Pharmaceuticals, Ministry of Chemicals & Fertilizers, The Federation of Indian Chambers of Commerce & Industry
(FICCI) and Invest India.
The award recognizes Glenmark’s multiple patents and innovations over the last three years, in its core therapy
areas of Dermatology, Respiratory and Oncology. It also acknowledges the company’s contribution to the
healthcare sector, in meeting both pressing and long-term patient needs.
Commenting on the award win, Mr. Glenn Saldanha, Chairman and Managing Director of Glenmark
Pharmaceuticals, said, “Now more than ever, we see the need for continuous innovation in pharma and
healthcare to address infectious and chronic diseases. Our goal at all times is to be future-ready, and to this
end, innovation is ingrained in all our efforts. We thank the government for its recognition; it serves as an
encouraging reminder to keep up our good work in India and the world.”
Glenmark has previously won awards from the Dept. of Pharmaceuticals under the categories of India Pharma
Leader Award (2015), Company of the Year (2016), and Corporate Social Responsibility Program of the Year